中科創達(300496.SZ):獨特的卡位優勢保證了公司的持續增長
格隆匯3月7日丨中科創達(300496.SZ)於2023年3月6日下午15:00-17:00召開2022年度網上業績説明會並表示,2022年第四季度,公司業務受到疫情影響,業務交付受到一些影響。此外,2022年第四季度,消費類電子出貨亦有波動。儘管如此,公司作為全球領先的智能操作系統產品和技術提供商,經過數年以來廣泛而深度的生態鏈資源整合,形成了難以複製的卡位優勢,這種獨特的卡位優勢保證了公司的持續增長。2022年度,公司整體及各個業務板塊取得了全面增長,公司實現營業收入544,545.36萬元,較上年同期增長31.96%,實現歸屬於上市公司股東的淨利潤76,877.2萬元,較上年同期增長18.77%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.